NRC NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

National Research Corp · Healthcare · Health Information Services

Open interactive chart View report data
Latest close 19.51 USD
-7.3% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 7.0% above the Trend Line and sits at 67.6% of its 52-week range. The latest completed week returned -7.3%, after a -12.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers. Options positioning is bullish with 51/100 conviction, while the latest news-sentiment score is 52/100.

Setup score 55 out of 100
Latest Close 19.51 USD 31 Jul 2026
1W Return -7.3% latest completed week
4W Return -12.9% short-term follow-through
12W Return 4.9% quarterly tape
Trend Breadth 65.4% 34 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 18-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -7.3% Latest completed week; four-week move -12.9%. Indicator stack 81/62 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 51/100 conviction; expected move 7.4%. News sentiment 52/100 33 relevant articles in the latest sentiment read. Event risk 27 Jul Latest stored earnings date was 27 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 7.0% above the Trend Line and sits at 67.6% of its 52-week range. The latest completed week returned -7.3%, after a -12.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7712-week average 0.71

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.77Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -12.9% over four weeks, 4.9% over 12 weeks, and 59.3% over one year. The current trend has remained active for 18 consecutive weeks.

Performance by holding period

1W-7.3%
4W-12.9%
12W4.9%
26W-3.2%
52W59.3%
Active trend streak18 weeks
Active weeks in one year34
Trend breadth65.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.71Latest activity-pressure read.
Pressure change-13.9%Four-week change in activity pressure.
Leadership6.84Latest relative-leadership reading.
RS change-66.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength54/100Blend of value, momentum, and quality. Underlying universe rank 47; rank 1 is best.
Value10/100Relative valuation strength. Underlying universe rank 91; rank 1 is best.
Quality96/100Profitability and accounting quality. Underlying universe rank 5; rank 1 is best.
Momentum87/100Medium-term price momentum. Underlying universe rank 14; rank 1 is best.
Growth1/100Revenue and earnings growth. Underlying universe rank 100; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
52.5x
Price divided by trailing earnings.
Price / sales
3.4x
Market value relative to trailing revenue.
EV / EBITDA
19.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
55.9%
Gross profit retained from each unit of revenue.
Operating margin
14.2%
Operating profit retained from revenue.
Free-cash-flow margin
26.4%
Free cash flow generated from revenue.
Return on invested capital
13.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-1.9%
Latest one-year revenue growth.
EPS growth
-62.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-16.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.9%
Cash dividends relative to market value.
Buyback yield
3.6%
Net share repurchases relative to market value.
Shareholder yield
6.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

NRC shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.00, expected move of 7.4%, and Sharemaestro trend signal active.

Conviction51/100
Expected move7.4%
Put/call volume0.00
Pressure100
Speculation3
Volatility63
Trend agreement7
Open options detail
Insider activity5 / 0

5 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 33 relevant articles.

8 positive · 19 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings27 JulLatest stored earnings date was 27 Jul 2026.
Options expected move7.4%Nearest-chain priced movement where available.
52-week drawdown-17.6%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+13.2%Week of 13 Mar.
Worst week-24.2%Week of 13 Feb.
Latest week-7.3%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks0
Modest losses9
Sharp losses4
Recent vol5.3%13-week weekly-return volatility.
Base vol8.5%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew6.9% / -5.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape61/100

Trend, activity pressure, participation, and risk combine to a 61/100 tape read.

 Indicator analysis81/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 8/12.

Activity pressure 0.77; No reversal markers Factors61/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 16; Small Cap Core rank 88 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options49/100

NRC shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.00, expected move of 7.4%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 7.4% Sentiment52/100

Weighted news tone is neutral across 33 relevant articles.

New NRC Health Research Reveals What Drives Patient Loyalty Beyond Access Insiders5 / 0

5 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings27 Jul

Latest stored earnings date was 27 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202619.51 USD-7.3%18.23 USD22.47 USD0.716.84712.1KOn
24 Jul 202621.04 USD-3.4%18.18 USD22.60 USD0.8316.38340.6KOn
17 Jul 202621.78 USD0.6%18.09 USD22.72 USD0.8819.14322.6KOn
10 Jul 202621.65 USD-3.3%17.98 USD22.83 USD0.7814.05437.7KOn
3 Jul 202622.40 USD7.6%17.83 USD22.94 USD0.8220.28399.9KOn
26 Jun 202620.81 USD13.1%17.61 USD23.05 USD0.9012.84643.0KOn
19 Jun 202618.40 USD-1.3%17.47 USD23.17 USD0.87-4.75644.1KOn
12 Jun 202618.65 USD-1.8%17.43 USD23.31 USD1.00-1.291.4MOn
5 Jun 202618.99 USD-2.0%17.31 USD23.45 USD0.932.59755.2KOn
29 May 202619.38 USD2.4%17.16 USD23.59 USD0.77-0.07407.2KOn
22 May 202618.93 USD2.5%16.95 USD23.74 USD0.560.52519.3KOn
15 May 202618.48 USD-0.7%16.70 USD23.87 USD0.18-0.67475.0KOn
8 May 202618.61 USD7.7%16.47 USD24.00 USD-0.08-0.31723.3KOn
1 May 202617.28 USD1.0%16.22 USD24.13 USD-0.33-2.31636.4KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.